Relationship between cervical cord 1H-magnetic resonance spectroscopy and clinoco-electromyographic profile in amyotrophic lateral sclerosis

Muscle and Nerve

Volumn 47, Issue 1, 2013, Pages 61-67

  Ikeda, Ken ^a   Murata, Kiyoko ^a   Kawase, Yuji ^a   Kawabe, Kiyokazu ^a   Kano, Osamu ^a   Yoshii, Yasuhiro ^a   Takazawa, Takanori ^a   Hirayama, Takehisa ^a   Iwasaki, Yasuo ^a  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Anterior horn cell damage; Cervical cord

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CERVICAL SPINAL CORD; CLINICAL ARTICLE; CONTROLLED STUDY; DENERVATION; DISEASE SEVERITY; ELECTROMYOGRAPHY; FEMALE; FORCED VITAL CAPACITY; FUNCTIONAL STATUS; HUMAN; MALE; NERVOUS SYSTEM DEVELOPMENT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RATING SCALE; SKELETAL MUSCLE; TISSUE LEVEL;

AMYOTROPHIC LATERAL SCLEROSIS; CERVICAL VERTEBRAE; CHOLINE; CREATINE; DISEASE PROGRESSION; ELECTROMYOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MOTOR CORTEX; MOTOR NEURONS; PHOSPHOCREATINE; SEVERITY OF ILLNESS INDEX; SPINAL CORD;

EID: 84871278626     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23467     Document Type: Article

References (26)

1. Brooks BR, Miller RG, Swash M, Munsat TL. World federation of neurology research group on motor neuron diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-299.
2. Moffett JR, Namboodiri MA, Cangro CB, Neale JH. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991; 2: 131-134.
3. Chang L, Ernst T, Osborn D, Seltzer W, Leonido-Yee M, Poland RE. Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats. Arch Neurol 1998; 55: 305-311.
4. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993; 13: 981-989.
5. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling. Nature 1989; 341: 197-205.
6. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15: 289-298.
7. Turner MR, Modo M. Advances in the application of MRI to amyotrophic lateral sclerosis. Expert Opin Med Diagn 2010; 4: 483-496.
8. Mitsumoto H, Ulug AM, Pullman SL, Gooch CL, Chan S, Tang MX, et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 2007; 68: 1402-1410.
9. Kalra S, Hanstock CC, Martin WR, Allen PS, Johnston WS. Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy. Arch Neurol 2006; 63: 1144-1148.
10. Unrath A, Ludolph AC, Kassubek J. Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study. J Neurol 2007; 254: 1099-1106.
11. 1H-MRS) on amyotrophic lateral sclerosis. J Magn Reson Imaging 2010; 31: 305-308.
12. Sivák S, Bittsansky M, Kurca E, Turcanova-Koprusakova M, Grofik M, Nosal' V, et al. Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis. Neuroradiology 2010; 52: 1079-1085.
13. 1H MRS of basal ganglia and thalamus in amyotrophic lateral sclerosis. NMR Biomed 2011; 24: 1270-1276.
14. Rule RR, Suhy J, Schuff N, Gelinas DF, Miller RG, Weiner MW. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph Lateral Scler Other Motor Neuron Disord 2004; 5: 141-149.
15. 1H MRSI. Neurology 2002; 58: 773-779.
16. Kalra S, Tai P, Genge A, Arnold DL. Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging. J Neurol 2006; 253: 1060-1063.
17. Khiat A, D'Amour M, Souchon F, Boulanger Y. MRS study of the effects of minocycline on markers of neuronal and microglial integrity in ALS. Magn Reson Imaging 2010; 28: 1456-1460.
18. Carew JD, Nair G, Pineda-Alonso N, Usher S, Hu X, Benatar M. Magnetic resonance spectroscopy of the cervical cord in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011; 12: 185-191.
19. Carew JD, Nair G, Andersen PM, Wuu J, Gronka S, Hu X, et al. Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS. Neurology 2011; 77: 1370-1375.
20. Cedarbaum JM, Stambler N, Malta E, Wuu J, Gronka S, Hu X, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNFALS Study Group (Phase III). J Neurol Sci 1999; 169: 13-21.
21. 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla. Neurology 1999; 53: 71-79.
22. de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008; 119: 497-503.
23. Ciccarelli O, Wheeler-Kingshott CA, McLean MA, Cercignani M, Wimpey K, Miller DH, et al. Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain 2007; 130: 2220-2231.
24. Ciccarelli O, Altmann DR, McLean MA, Wheeler-Kingshott CA, Wimpey K, Miller DH, et al. Spinal cord repair in MS: does mitochondrial metabolism play a role? Neurology 2010; 74: 721-727.
25. Marliani AF, Clementi V, Albini Riccioli L, Agati R, Carpenzano M, Salvi F, et al. Quantitative cervical spinal cord 3T proton MR spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 2010; 31: 180-184.
26. He J, Inglese M, Li BS, Babb JS, Grossman RI, Gonen O. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience. Radiology 2005; 234: 211-217.